Loading…

Effect of different charges of modified electroconvulsive seizure on the cognitive behavior in stressed rats: Effects of GluR1 phosphorylation and CaMKIIα activity

Electroconvulsive therapy (ECT) is an efficient therapy for major depression and modern ECT requires anesthesia to enhance safety. However, the commonly used anesthetic, propofol, may weaken the treatment efficacy. A recent study confirmed that ketamine rapidly reduced the symptoms of depression in...

Full description

Saved in:
Bibliographic Details
Published in:Experimental and therapeutic medicine 2019-01, Vol.17 (1), p.748-758
Main Authors: Zhang, Fan, Huang, Guihua, Zhu, Xianlin
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c3562-11bd69fb55d3fca665a93ac26b2825da933e66656b0d201e59e7d3e0ac941d643
container_end_page 758
container_issue 1
container_start_page 748
container_title Experimental and therapeutic medicine
container_volume 17
creator Zhang, Fan
Huang, Guihua
Zhu, Xianlin
description Electroconvulsive therapy (ECT) is an efficient therapy for major depression and modern ECT requires anesthesia to enhance safety. However, the commonly used anesthetic, propofol, may weaken the treatment efficacy. A recent study confirmed that ketamine rapidly reduced the symptoms of depression in affected patients. A previous study found that electroconvulsive seizure (ECS), the animal model for ECT, under anesthesia of low-dose ketamine combined with propofol could enhance the antidepressant efficacy and improve the cognitive performance. The present study aimed to investigate the responses to different charges (0, 60, 120, 180 or 240 mC) of ECS under compound anesthetics, ketamine combined with propofol, in stressed rats and the underlying mechanisms to aid in optimization of treatment regimens. The results indicated that ECS exhibited an improved antidepressant effects at 120 mC compared with 60 mC, however, no significant differences in antidepressant effects were identified among the 120, 180 and 240 mC groups. Furthermore, rats subjected to ECS at 120 mC exhibited the best cognitive performance. The phosphorylation levels of calcium/calmodulin-dependent protein kinase IIα (CaMKIIα) at Thr286, glutamate receptor 1 (GluR1) at Ser831 and cAMP-response element-binding protein (CREB) at the Ser133 were higher in the 120-mC group compared with all other groups. These results indicated that the ECS at medium intensity (120 mC) with administration of compound anesthetics may exert an improved therapeutic effect on depression compared with other intensities (0, 60, 180 and 240 mC). The results also suggested that the improvement in cognitive function in stressed rats may be attributed to the phosphorylation of CaMKIIα (Thr286), GluR1 (Ser831) and CREB (Ser133).
doi_str_mv 10.3892/etm.2018.7022
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6307485</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2179378347</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3562-11bd69fb55d3fca665a93ac26b2825da933e66656b0d201e59e7d3e0ac941d643</originalsourceid><addsrcrecordid>eNpdUs2KFDEQbkRxl3WPXiXgxcvM5meS7vYgyLCugyuC6Dmkk-rpLN2dMUkPjM_jC_giPpPVO-OiBkIqVV--1M9XFM8ZXYqq5leQhyWnrFqWlPNHxTkra75glMnHJ5vWFTsrLlO6o7ikYlUlnxZngirJKlmfFz-u2xZsJqElzqMZYczEdiZuIc3OIaDbgyPQIywGG8b91Ce_B5LAf58ikDCS3AGxYTv6PAca6Mzeh0j8SFKOkBK-jyan1-T42z3zTT99ZmTXhYQ7HnqTPTKZ0ZG1-fhhs_n1kxiLfD4fnhVPWtMnuDydF8XXd9df1u8Xt59uNuu3twsrpMLCWeNU3TZSOtFao5Q0tTCWq4ZXXDq8CFDoVQ112DWQNZROADW2XjGnVuKieHPk3U3NAM5iL6Lp9S76wcSDDsbrfyOj7_Q27LUStFxVEglenQhi-DZBynrwyULfmxHClDTHoYiyEqsSoS__g96FKY5YHqIUL2mp-JzR4oiyMaQUoX1IhlE9S0CjBPQsAT1LAPEv_q7gAf1n4OI3ZgWw1w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2162707624</pqid></control><display><type>article</type><title>Effect of different charges of modified electroconvulsive seizure on the cognitive behavior in stressed rats: Effects of GluR1 phosphorylation and CaMKIIα activity</title><source>PMC</source><creator>Zhang, Fan ; Huang, Guihua ; Zhu, Xianlin</creator><creatorcontrib>Zhang, Fan ; Huang, Guihua ; Zhu, Xianlin</creatorcontrib><description>Electroconvulsive therapy (ECT) is an efficient therapy for major depression and modern ECT requires anesthesia to enhance safety. However, the commonly used anesthetic, propofol, may weaken the treatment efficacy. A recent study confirmed that ketamine rapidly reduced the symptoms of depression in affected patients. A previous study found that electroconvulsive seizure (ECS), the animal model for ECT, under anesthesia of low-dose ketamine combined with propofol could enhance the antidepressant efficacy and improve the cognitive performance. The present study aimed to investigate the responses to different charges (0, 60, 120, 180 or 240 mC) of ECS under compound anesthetics, ketamine combined with propofol, in stressed rats and the underlying mechanisms to aid in optimization of treatment regimens. The results indicated that ECS exhibited an improved antidepressant effects at 120 mC compared with 60 mC, however, no significant differences in antidepressant effects were identified among the 120, 180 and 240 mC groups. Furthermore, rats subjected to ECS at 120 mC exhibited the best cognitive performance. The phosphorylation levels of calcium/calmodulin-dependent protein kinase IIα (CaMKIIα) at Thr286, glutamate receptor 1 (GluR1) at Ser831 and cAMP-response element-binding protein (CREB) at the Ser133 were higher in the 120-mC group compared with all other groups. These results indicated that the ECS at medium intensity (120 mC) with administration of compound anesthetics may exert an improved therapeutic effect on depression compared with other intensities (0, 60, 180 and 240 mC). The results also suggested that the improvement in cognitive function in stressed rats may be attributed to the phosphorylation of CaMKIIα (Thr286), GluR1 (Ser831) and CREB (Ser133).</description><identifier>ISSN: 1792-0981</identifier><identifier>EISSN: 1792-1015</identifier><identifier>DOI: 10.3892/etm.2018.7022</identifier><identifier>PMID: 30651859</identifier><language>eng</language><publisher>Greece: Spandidos Publications UK Ltd</publisher><subject>Anesthesia ; Animal cognition ; Antidepressants ; Behavior disorders ; Cognitive ability ; Kinases ; Laboratory animals ; Medical research ; Mental depression ; Phosphorylation ; Proteins ; Rodents ; Studies</subject><ispartof>Experimental and therapeutic medicine, 2019-01, Vol.17 (1), p.748-758</ispartof><rights>Copyright Spandidos Publications UK Ltd. 2019</rights><rights>Copyright: © Zhang et al. 2019</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3562-11bd69fb55d3fca665a93ac26b2825da933e66656b0d201e59e7d3e0ac941d643</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307485/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307485/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30651859$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhang, Fan</creatorcontrib><creatorcontrib>Huang, Guihua</creatorcontrib><creatorcontrib>Zhu, Xianlin</creatorcontrib><title>Effect of different charges of modified electroconvulsive seizure on the cognitive behavior in stressed rats: Effects of GluR1 phosphorylation and CaMKIIα activity</title><title>Experimental and therapeutic medicine</title><addtitle>Exp Ther Med</addtitle><description>Electroconvulsive therapy (ECT) is an efficient therapy for major depression and modern ECT requires anesthesia to enhance safety. However, the commonly used anesthetic, propofol, may weaken the treatment efficacy. A recent study confirmed that ketamine rapidly reduced the symptoms of depression in affected patients. A previous study found that electroconvulsive seizure (ECS), the animal model for ECT, under anesthesia of low-dose ketamine combined with propofol could enhance the antidepressant efficacy and improve the cognitive performance. The present study aimed to investigate the responses to different charges (0, 60, 120, 180 or 240 mC) of ECS under compound anesthetics, ketamine combined with propofol, in stressed rats and the underlying mechanisms to aid in optimization of treatment regimens. The results indicated that ECS exhibited an improved antidepressant effects at 120 mC compared with 60 mC, however, no significant differences in antidepressant effects were identified among the 120, 180 and 240 mC groups. Furthermore, rats subjected to ECS at 120 mC exhibited the best cognitive performance. The phosphorylation levels of calcium/calmodulin-dependent protein kinase IIα (CaMKIIα) at Thr286, glutamate receptor 1 (GluR1) at Ser831 and cAMP-response element-binding protein (CREB) at the Ser133 were higher in the 120-mC group compared with all other groups. These results indicated that the ECS at medium intensity (120 mC) with administration of compound anesthetics may exert an improved therapeutic effect on depression compared with other intensities (0, 60, 180 and 240 mC). The results also suggested that the improvement in cognitive function in stressed rats may be attributed to the phosphorylation of CaMKIIα (Thr286), GluR1 (Ser831) and CREB (Ser133).</description><subject>Anesthesia</subject><subject>Animal cognition</subject><subject>Antidepressants</subject><subject>Behavior disorders</subject><subject>Cognitive ability</subject><subject>Kinases</subject><subject>Laboratory animals</subject><subject>Medical research</subject><subject>Mental depression</subject><subject>Phosphorylation</subject><subject>Proteins</subject><subject>Rodents</subject><subject>Studies</subject><issn>1792-0981</issn><issn>1792-1015</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNpdUs2KFDEQbkRxl3WPXiXgxcvM5meS7vYgyLCugyuC6Dmkk-rpLN2dMUkPjM_jC_giPpPVO-OiBkIqVV--1M9XFM8ZXYqq5leQhyWnrFqWlPNHxTkra75glMnHJ5vWFTsrLlO6o7ikYlUlnxZngirJKlmfFz-u2xZsJqElzqMZYczEdiZuIc3OIaDbgyPQIywGG8b91Ce_B5LAf58ikDCS3AGxYTv6PAca6Mzeh0j8SFKOkBK-jyan1-T42z3zTT99ZmTXhYQ7HnqTPTKZ0ZG1-fhhs_n1kxiLfD4fnhVPWtMnuDydF8XXd9df1u8Xt59uNuu3twsrpMLCWeNU3TZSOtFao5Q0tTCWq4ZXXDq8CFDoVQ112DWQNZROADW2XjGnVuKieHPk3U3NAM5iL6Lp9S76wcSDDsbrfyOj7_Q27LUStFxVEglenQhi-DZBynrwyULfmxHClDTHoYiyEqsSoS__g96FKY5YHqIUL2mp-JzR4oiyMaQUoX1IhlE9S0CjBPQsAT1LAPEv_q7gAf1n4OI3ZgWw1w</recordid><startdate>20190101</startdate><enddate>20190101</enddate><creator>Zhang, Fan</creator><creator>Huang, Guihua</creator><creator>Zhu, Xianlin</creator><general>Spandidos Publications UK Ltd</general><general>D.A. Spandidos</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20190101</creationdate><title>Effect of different charges of modified electroconvulsive seizure on the cognitive behavior in stressed rats: Effects of GluR1 phosphorylation and CaMKIIα activity</title><author>Zhang, Fan ; Huang, Guihua ; Zhu, Xianlin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3562-11bd69fb55d3fca665a93ac26b2825da933e66656b0d201e59e7d3e0ac941d643</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Anesthesia</topic><topic>Animal cognition</topic><topic>Antidepressants</topic><topic>Behavior disorders</topic><topic>Cognitive ability</topic><topic>Kinases</topic><topic>Laboratory animals</topic><topic>Medical research</topic><topic>Mental depression</topic><topic>Phosphorylation</topic><topic>Proteins</topic><topic>Rodents</topic><topic>Studies</topic><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Fan</creatorcontrib><creatorcontrib>Huang, Guihua</creatorcontrib><creatorcontrib>Zhu, Xianlin</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing &amp; Allied Health Database</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Experimental and therapeutic medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Fan</au><au>Huang, Guihua</au><au>Zhu, Xianlin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of different charges of modified electroconvulsive seizure on the cognitive behavior in stressed rats: Effects of GluR1 phosphorylation and CaMKIIα activity</atitle><jtitle>Experimental and therapeutic medicine</jtitle><addtitle>Exp Ther Med</addtitle><date>2019-01-01</date><risdate>2019</risdate><volume>17</volume><issue>1</issue><spage>748</spage><epage>758</epage><pages>748-758</pages><issn>1792-0981</issn><eissn>1792-1015</eissn><abstract>Electroconvulsive therapy (ECT) is an efficient therapy for major depression and modern ECT requires anesthesia to enhance safety. However, the commonly used anesthetic, propofol, may weaken the treatment efficacy. A recent study confirmed that ketamine rapidly reduced the symptoms of depression in affected patients. A previous study found that electroconvulsive seizure (ECS), the animal model for ECT, under anesthesia of low-dose ketamine combined with propofol could enhance the antidepressant efficacy and improve the cognitive performance. The present study aimed to investigate the responses to different charges (0, 60, 120, 180 or 240 mC) of ECS under compound anesthetics, ketamine combined with propofol, in stressed rats and the underlying mechanisms to aid in optimization of treatment regimens. The results indicated that ECS exhibited an improved antidepressant effects at 120 mC compared with 60 mC, however, no significant differences in antidepressant effects were identified among the 120, 180 and 240 mC groups. Furthermore, rats subjected to ECS at 120 mC exhibited the best cognitive performance. The phosphorylation levels of calcium/calmodulin-dependent protein kinase IIα (CaMKIIα) at Thr286, glutamate receptor 1 (GluR1) at Ser831 and cAMP-response element-binding protein (CREB) at the Ser133 were higher in the 120-mC group compared with all other groups. These results indicated that the ECS at medium intensity (120 mC) with administration of compound anesthetics may exert an improved therapeutic effect on depression compared with other intensities (0, 60, 180 and 240 mC). The results also suggested that the improvement in cognitive function in stressed rats may be attributed to the phosphorylation of CaMKIIα (Thr286), GluR1 (Ser831) and CREB (Ser133).</abstract><cop>Greece</cop><pub>Spandidos Publications UK Ltd</pub><pmid>30651859</pmid><doi>10.3892/etm.2018.7022</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1792-0981
ispartof Experimental and therapeutic medicine, 2019-01, Vol.17 (1), p.748-758
issn 1792-0981
1792-1015
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6307485
source PMC
subjects Anesthesia
Animal cognition
Antidepressants
Behavior disorders
Cognitive ability
Kinases
Laboratory animals
Medical research
Mental depression
Phosphorylation
Proteins
Rodents
Studies
title Effect of different charges of modified electroconvulsive seizure on the cognitive behavior in stressed rats: Effects of GluR1 phosphorylation and CaMKIIα activity
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T06%3A55%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20different%20charges%20of%20modified%20electroconvulsive%20seizure%20on%20the%20cognitive%20behavior%20in%20stressed%20rats:%20Effects%20of%20GluR1%20phosphorylation%20and%20CaMKII%CE%B1%20activity&rft.jtitle=Experimental%20and%20therapeutic%20medicine&rft.au=Zhang,%20Fan&rft.date=2019-01-01&rft.volume=17&rft.issue=1&rft.spage=748&rft.epage=758&rft.pages=748-758&rft.issn=1792-0981&rft.eissn=1792-1015&rft_id=info:doi/10.3892/etm.2018.7022&rft_dat=%3Cproquest_pubme%3E2179378347%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3562-11bd69fb55d3fca665a93ac26b2825da933e66656b0d201e59e7d3e0ac941d643%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2162707624&rft_id=info:pmid/30651859&rfr_iscdi=true